Literature DB >> 12839098

Validation of the Wisconsin Personality Disorders Inventory-IV with the SCID-II.

Tracey L Smith1, Marjorie H Klein, Lorna S Benjamin.   

Abstract

The Wisconsin Personality Disorders Inventory (WISPI-IV; Klein & Benjamin, 1996) is the latest version of a self-report measure of DSM-IV personality disorders (PDs) derived from an interpersonal perspective. When categorical diagnoses derived from the WISPI-IV were compared with independent SCID-II diagnoses, the majority of the kappas were poor (>.40). However, all but one of the effect sizes for the differences in WISPI-IV means between groups with and without SCID-II diagnoses were large (>.80). When SCID-II and WISPI-IV dimensional scores were considered, the average r between profiles was .61 (median = .58) and correlations between corresponding PD scales (mean diagonal r = .48; mean off-diagonal r = .18) indicated good convergent and discriminant validity for five of the WISPI-IV scales. These results add to the cumulating evidence suggesting greater reliability and validity of dimensional over categorical scores for PDs. Researchers and clinicians interested in having an efficient method of assessing PDs may consider using a dimensional approach such as the WISPI-IV as an alternative to diagnostic interview.

Entities:  

Mesh:

Year:  2003        PMID: 12839098     DOI: 10.1521/pedi.17.3.173.22150

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  3 in total

1.  The Personality Disorders Institute/Borderline Personality Disorder Research Foundation Randomized Control Trial for Borderline Personality Disorder: reliability of Axis I and II diagnoses.

Authors:  Kenneth L Critchfield; Kenneth N Levy; John F Clarkin
Journal:  Psychiatr Q       Date:  2007-03

2.  Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Authors:  Gholson J Lyon; Tao Jiang; Richard Van Wijk; Wei Wang; Paul Mark Bodily; Jinchuan Xing; Lifeng Tian; Reid J Robison; Mark Clement; Yang Lin; Peng Zhang; Ying Liu; Barry Moore; Joseph T Glessner; Josephine Elia; Fred Reimherr; Wouter W van Solinge; Mark Yandell; Hakon Hakonarson; Jun Wang; William Evan Johnson; Zhi Wei; Kai Wang
Journal:  Discov Med       Date:  2011-07       Impact factor: 2.970

3.  The effect of personality disorder symptoms on response to treatment with methylphenidate transdermal system in adults with attention-deficit/hyperactivity disorder.

Authors:  John L Olsen; Frederick W Reimherr; Barrie K Marchant; Paul H Wender; Reid J Robison
Journal:  Prim Care Companion CNS Disord       Date:  2012-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.